Min Li is the founder of SciNeuro. SciNeuro has raised $153M in total funding. Latest round: Series B. Based in Rockville, Maryland, United States.
Min Li is the founder and Chief Executive Officer of SciNeuro Pharmaceuticals, a clinical-stage neuromedicine company. He has led the company since its establishment in 2020, overseeing two major financing rounds totaling $153 million and securing a landmark licensing agreement with Novartis.
Full founder directory · Investor directory · Company funding database · Fundraising library